A study from a large national health plan evaluating persistence and compliance of osteoporosis therapies in postmenopausal women.
Phase of Trial: Phase IV
Latest Information Update: 03 Jan 2017
At a glance
- Drugs Alendronic acid (Primary) ; Denosumab (Primary) ; Ibandronic acid (Primary) ; Raloxifene (Primary) ; Risedronic acid (Primary) ; Teriparatide (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 03 Jan 2017 New trial record